168
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention

ORCID Icon, , , , , , , , , & show all
Pages 95-101 | Published online: 18 Feb 2020

References

  • Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104(6):636–641. doi:10.1161/hc3101.093701
  • Ramjane K, Han L, Jin C. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol. 2008;13(3):121–128.
  • Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation. 1994;89(6):2514–2518. doi:10.1161/01.CIR.89.6.2514
  • Resnic FS, Wainstein M, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003;145(1):42–46. doi:10.1067/mhj.2003.36
  • Cenko E, Ricci B, Kedev S, et al. The no-reflow phenomenon in the young and in the elderly. Int J Cardiol. 2016;222:1122–1128. doi:10.1016/j.ijcard.2016.07.209
  • Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no reflow’ phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93(2):223–228. doi:10.1161/01.CIR.93.2.223
  • Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93(11):1993–1999. doi:10.1161/01.CIR.93.11.1993
  • Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94(6):1269–1275. doi:10.1161/01.CIR.94.6.1269
  • Ramírez-Moreno A, Cardenal R, Pera C, et al. Predictors and prognostic value of myocardial injury following stent implantation. Int J Cardiol. 2004;97(2):193–198. doi:10.1016/j.ijcard.2003.07.031
  • Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarctrelated arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest. 2002;122(4):1322–1332. doi:10.1378/chest.122.4.1322
  • Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation. 2005;112(15):2364–2372. doi:10.1161/CIRCULATIONAHA.104.481283
  • Rossello X, Pujadas S, Serra A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol. 2016;117(5):720–726. doi:10.1016/j.amjcard.2015.12.001
  • Hoebers LP, Claessen BE, Elias J, Dangas GD, Mehran R, Henriques JP. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90–96. doi:10.1016/j.ijcard.2015.03.164
  • Tomasello SD, Boukhris M, Giubilato S, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian registry of chronic total occlusions. Eur Heart J. 2015;36(45):3189–3198. doi:10.1093/eurheartj/ehv450
  • Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: the thoraxcenter experience 1992–2002. Eur Heart J. 2005;26(24):2630–2636. doi:10.1093/eurheartj/ehi498
  • Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653. doi:10.1161/CIRCULATIONAHA.107.187397
  • Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ. Management of the no-reflow phenomenon. Pharmacol Ther. 2011;132(1):72–85.
  • Wong DT, Puri R, Richardson JD, Worthley MI, Worthley SG. Myocardial ‘no-reflow’— diagnosis, pathophysiology and treatment. Int J Cardiol. 2013;167(5):1798–1806. doi:10.1016/j.ijcard.2012.12.049
  • Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diab Vasc Dis Res. 2005;2(3):136–143. doi:10.3132/dvdr.2005.021
  • Goodwill AG, Stapleton PA, James ME, D’Audiffret AC, Frisbee JC. Increased arachidonic acid-induced thromboxane generation impairs skeletal muscle arteriolar dilation with genetic dyslipidemia. Microcirculation. 2008;15(7):621–631. doi:10.1080/10739680802308334
  • Iwakura K, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27(5):534–539. doi:10.1093/eurheartj/ehi715
  • Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol. 2010;56(14):1099–1109. doi:10.1016/j.jacc.2010.04.023
  • Manfrini O, Pizzi C, Morgagni G, Fontana F, Bugiardini R. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty, Am. J Cardiol. 2004;93(11):1391–1393. doi:10.1016/j.amjcard.2004.02.037
  • Kurtul A, Murat SN, Yarlioglues M, Duran M, Celik IE, Kilic A. Mild to moderate renal impairment is associated with no-refowphenomenonafter primary percutaneous coronary intervention in acute myocardial infarction. Angiology. 2015;66(7):644–651. doi:10.1177/0003319714546738
  • Oduncu V, Tanalp AC, Erkol A, et al. Impact of chronic pre-treatment of statins on the level of systemic infammation and myocardial perfusion in patients undergoing primary angioplasty. Am J Cardiol. 2011;107(2):179–185. doi:10.1016/j.amjcard.2010.09.008
  • Zhao Y, Yang J, Ji Y, et al. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Vessels. 2019;34(10):1600–1607. doi:10.1007/s00380-019-01399-w
  • Butler, M, Ajani, A, Andrianopoulos, N, et al. Predictors and outcomes of the no-reflow phenomenon. Heart Lung Circ. 17(S3):S176.